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Abstract
Imerslund-Gräsbeck syndrome is a rare condition caused by vitamin 
B12 deficiency and proteinuria. In this article, we reported the case of 
a 10-year-old girl with imbalance and urinary incontinence. The case 
had cerebellar ataxia as the primary manifestation. The disequilibrium 
had progressed gradually within three weeks and was consistent with 
the symptoms of cerebellar involvement and urinary incontinence. 
Brain and cervico-thoraco-lumbar magnetic resonance imaging were 
normal. The patient had elevated lactate dehydrogenase (LDH=4775 
IU/L), in addition to macrocytic anemia, on laboratory examinations; 
thus, the possibility of malignancy was raised. Then, bone marrow 
aspiration was performed, showing hypercellular marrow with 
megaloblastic changes. This finding proved megaloblastic anemia. 
Regarding the low prevalence of vitamin B12 deficiency in healthy 
individuals, extensive studies were performed to find out the cause. 
The serum level of vitamin B12 was found to be lower than the normal 
range. Although urinalysis revealed significant proteinuria, further 
nephrological investigations did not indicate any abnormalities. No 
evidence of serious problems  was observed in the gastrointestinal 
tract study, and metabolic studies were normal. Finally, based on the 
obtained data, Imerslund-Gräsbeck syndrome was recognized. Patient 
was treated by vitamin B12 injection, leading to improved balance, 
and in one-month follow-up, she was able to walk independently, 
and the cerebellar symptoms had greatly disappeared; however, 
proteinuria persisted.
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Introduction
Imerslund-Gräsbeck syndrome is a rare syndrome 
caused by low levels of vitamin B12 (vitamin 
B12 deficiency) (1). The primary feature of this 
condition is a blood disorder called megaloblastic 
anemia (2). In this form of anemia, red blood cells 
are abnormally large, and its count is diminished 
(3). About half of people with Imerslund-Gräsbeck 
syndrome also have high protein levels in their 
urine (proteinuria) (4). Although proteinuria can 
be an indication of kidney problems, patients with 
Imerslund-Gräsbeck syndrome appear to have 
normal kidney function (5). The incidence of this 
syndrome is 1:200,000 cases (6). Four hundred 
cases of this condition have been published and 
reported so far. This syndrome usually occurs in 
the first two years of life in the form of anemia with 
proteinuria as well as neurological symptoms.  In 
this article, we reported a new case of Imerslund-
Gräsbeck syndrome with acute cerebellar ataxia as 
the first manifestation. 
Case Presentation
A 10-year-old girl was referred to our center due 
to a lack of balance and urinary incontinence from 
three weeks ago. The patient was the third child of 
consanguineous parents. Nervous development of 
the patient was normal before the onset of disease. 
The disequilibrium had progressed gradually and 
was consistent with the symptoms of cerebellar 
involvement and urinary incontinence. Due to 
prior low-grade fever, the patient had been treated 
with the suspicion of viral cerebellitis in the 
previous center and then referred to us owing to 
the worsening of symptoms.
During the physical examination, the patient was 
unable to sit and walk independently, and cerebellar 
tests, including finger to nose and tandem gait, were 
abnormal, deep tendon reflexes were diminished, 
and Babinski sign was detected bilaterally
Brain and cervico-thoraco-lumbar magnetic 
resonance imaging was performed for further 
investigation. These tests were normal. Lumbar 
puncture was also normal (glucose= 50 mg/
dl, protein= 30 mg/dl white blood cell= 3, and 
red blood cell= 0). High concentration of lactate 
dehydrogenase (LDH= 4775 IU/L) and anemia 
(Hb= 8.8 gr/dl, mean corpuscular volume=104 
fL, Red blood cell= 2540000/micro liter, platelet= 
163000/microliter) were detected in biochemical 
tests. Thus, the possibility of malignancy was 
raised. Organomegaly and lymphadenopathy 
were not seen in abdominal sonography, and 
hypercellular marrow with megaloblastic changes 
was observed in bone marrow examination. In 
addition to these data, elevated mean corpuscular 
volume (MCV=104 fL) with hyper segmented 
neutrophil in peripheral blood smear was noted, 
and the diagnosis of megaloblastic anemia was 
established. Consequently, vitamin B12 and folate 
levels were assessed. The serum level of vitamin 
B12 was found to be 70.41 pg/ml., which was 
significantly lower than the normal range (160-970 
pg/ml). The range of folate was also normal. 
Regarding the low prevalence of vitamin B12 
deficiency in healthy persons, extensive studies 
have been performed to find out the cause. In order 
to rule out atrophic gastritis, gastric and duodenal 
endoscopy and biopsy were performed. The data 
from the stomach and upper gastrointestinal tract 
were normal. There was no evidence for celiac 
disease in duodenal biopsy, and serum anti-tissue 
transglutaminase (TTG) was within the normal 
range. Gastrointestinal transit evaluation showed 
no defect in the mucous membranes of jejunum 
and ileum. Thus, gastrointestinal disorders 
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were rejected. In urinalysis,  2+ proteinuria was 
observed with no leukocyturia and hematuria. 
Further nephrological evaluations, including renal 
sonography and other specific tests, demonstrated 
proteinuria (random urine protein/creatine ratio 
was 1)  with an unknown etiology. To rule out 
the metabolic disorders that can interfere with the 
metabolism of vitamin B12, chromatography of 
blood amino acids, urine organic acids assessment, 
and tandem mass spectrometry were carried out, 
but no abnormality was detected.
Finally, based on the investigations and hematologic 
and nephrological findings, the diagnosis of 
Imerslund-Gräsbeck syndrome was established. 
The patient was treated with a high dose of 
vitamin B12 daily injection (1000 microgram 
intramuscular) for one week, followed by 1000 
microgram weekly, leading to improved balance. 
In one-month follow-up, she was able to walk, 
her cerebellar symptoms had greatly disappeared, 
and the patient had no incontinency; however, 
proteinuria persisted.
Discussion
Imerslund- Gräsbeck syndrome, which is an 
autosomal recessive disorder, was first reported 
by Lin et al. in China (7). Megaloblastic anemia 
is the most common clinical manifestation of this 
disorder because of the selective malabsorption of 
vitamin B12 (8). The cause of the condition is a 
defect in the receptor of the vitamin B12-intrinsic 
factor complex of the ileal enterocyte (9). There 
are different other manifestations of this disease, 
including failure to thrive, anatomical anomalies 
in the urinary tract, and neurological damages 
(2). Proteinuria without signs of kidney disease is 
also observed in more than 50% of these patients 
(10, 11). This malabsorption is related to ileal 
receptors’ malfunction that is proved by classic 
Schilling’s test. There are three typical features 
for Imerslund-Gräsbeck syndrome, namely 
macrocytic anemia, decreased serum B12 level, 
and proteinuria (12, 13).  In our case, macrocytic 
anemia with megaloblastic changes was detected 
due to decreased B12 level, while no defect in the 
mucous membranes of jejunum and ileum was 
observed. Overall, 50-70% of such patients show 
proteinuria following megaloblastic anemia (10, 
11).  
In our case, this symptom was also detected. We 
also performed metabolic studies, including urine 
organic acids and blood amino acid chromatography, 
yielding no further findings. Based on macrocytic 
anemia, neurological findings, low level of vitamin 
B12, and proteinuria, the diagnosis of Imerslund-
Gräsbeck syndrome was confirmed. At the time 
of first visit, the patient was not able to walk. 
This disequilibrium had progressed gradually and 
was consistent with the symptoms of cerebellar 
involvement and urinary incontinence; however, 
imaging studies were normal. These signs in 
Imerslund-Gräsbeck syndrome are rare, and to 
date, no cases with these manifestations have 
been reported (14). Therefore, the novelty of this 
reported case lies in acute 
cerebellar ataxia and urinary incontinence as the 
primary clinical manifestations.
In Conclusion
Imerslund-Gräsbeck syndrome is a rare disorder 
which  typically presents with megaloblastic 
anemia and  failure to thrive  in infancy,In 
this article we present  a 10 year-old girl with 
cerebellar atxia who was eventually diagnosed 
with Imerslund-Gräsbeck syndrome. This  case 
declares the diverse neurological manifestation of 
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this syndrome and it shows that  physicians should 
be aware about Imerslund-Gräsbeck syndrome 
when diagnosing ataxia.
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